What is Multiple Sclerosis?
Multiple sclerosis (or
MS) is a chronic, often disabling disease that attacks the central nervous
system (CNS), which is made up of the brain, spinal cord, and optic nerves.
Symptoms may be mild, such as numbness in the limbs, or severe, such as
paralysis or loss of vision. The progress, severity, and specific symptoms of
MS are unpredictable and vary from one person to another. Today, new treatments
and advances in research are giving new hope to people affected by the disease.
MS is a Disease of the Immune System
MS is a disease that
involves an immune system attack against the central nervous system
(brain, spinal cord, and optic nerves). The disease is thought to be
triggered in a genetically susceptible individual by a combination of one or
more environmental factors. Although MS is thought by some scientists to
be an autoimmine disease, others disagree strongly because the
specific target of the immune attack in MS has not yet been identified. For
this reason, MS is referred to as animmune-mediated disease.
As part of the immune
attack on the central nervous system, myelin (the fatty
substance that surrounds and protects the nerve fibers in the central nervous
system) is damaged, as well as the nerve fibers themselves. The damaged myelin
forms scar tissue (sclerosis), which gives the disease its name. When any part
of the myelin sheath or nerve fiber is damaged or destroyed, nerve impulses
traveling to and from the brain and spinal cord are distorted or interrupted,
producing the variety of symptoms that can occur.
Most people with MS
learn to cope with the disease and continue to lead satisfying, productive
lives.
The Four Courses of MS
People with MS can
typically experience one of four disease
courses, each of which might be mild, moderate, or severe.
·
Relapsing-Remitting MS
People with this type
of MS experience clearly defined attacks of worsening neurologic function.
These attacks—which are called relapses, flare-ups, or exacerbations —are
followed by partial or complete recovery periods (remissions), during which no
disease progression occurs. Approximately 85% of people are initially diagnosed
with relapsing-remitting MS.
·
Primary-Progressive MS
This disease course is
characterized by slowly worsening neurologic function from the beginning—with
no distinct relapses or remissions. The rate of progression may vary over time,
with occasional plateaus and temporary minor improvements. Approximately 10% of
people are diagnosed with primary-progressive MS.
·
Secondary-Progressive MS
Following an initial
period of relapsing-remitting MS, many people develop a secondary-progressive
disease course in which the disease worsens more steadily, with or without
occasional flare-ups, minor recoveries (remissions), or plateaus. Before the
disease-modifying medications became available, approximately 50% of people
with relapsing-remitting MS developed this form of the disease within 10 years.
Long-term data are not yet available to determine if treatment significantly
delays this transition.
·
Progressive-Relapsing MS
In this relatively
rare course of MS (5%), people experience steadily worsening disease from the
beginning, but with clear attacks of worsening neurologic function along the
way. They may or may not experience some recovery following these relapses, but
the disease continues to progress without remissions.
Since no two people
have exactly the same experience of MS, the disease course may look very
different from one person to another. And, it may not always be clear to the
physician—at least right away—which course a person is experiencing.
People with this type of MS experience clearly defined attacks of worsening neurologic function. These attacks—which are called relapses, flare-ups, or exacerbations —are followed by partial or complete recovery periods (remissions), during which no disease progression occurs. Approximately 85% of people are initially diagnosed with relapsing-remitting MS.
This disease course is characterized by slowly worsening neurologic function from the beginning—with no distinct relapses or remissions. The rate of progression may vary over time, with occasional plateaus and temporary minor improvements. Approximately 10% of people are diagnosed with primary-progressive MS.
Following an initial period of relapsing-remitting MS, many people develop a secondary-progressive disease course in which the disease worsens more steadily, with or without occasional flare-ups, minor recoveries (remissions), or plateaus. Before the disease-modifying medications became available, approximately 50% of people with relapsing-remitting MS developed this form of the disease within 10 years. Long-term data are not yet available to determine if treatment significantly delays this transition.
In this relatively rare course of MS (5%), people experience steadily worsening disease from the beginning, but with clear attacks of worsening neurologic function along the way. They may or may not experience some recovery following these relapses, but the disease continues to progress without remissions.
No comments:
Post a Comment